Introduction {#s0005}
============

Retinopathy of prematurity (ROP) is a disorder in which retinal blood vessels fail to develop normally, sometimes resulting in visual impairment and blindness in premature infants. In the early stages of retinal vascular development, premature neonates are exposed to higher oxygen levels eliminating physiological hypoxia, thus down-regulating angiogenic factors that are required for the growth of the vasculature. ROP occurs in premature infants with disruption of this angiogenic phase. Vascular endothelial growth factor (VEGF) plays an important role in both physiological and pathologic angiogenesis. Discovery of growth factors acting on the vascular endothelium has coincided with application of powerful new genetic approaches to the problem of vascular development. A number of studies have investigated and observed that VEGF messenger ribonucleic acid (mRNA) and protein were significantly higher in ROP, which supported a key role for *VEGF* in the pathological angiogenesis in ROP.[@b0005], [@b0010]

The human VEGF gene (OMIM [192240](192240){#ir040}) is located on chromosome 6p12. Many polymorphisms of the VEGF gene have been reported, although most are relatively rare. Single nucleotide polymorphisms (SNPs) in the VEGF −460 T/C (rs833061) and +936 C/T (rs3025039) in the respective 5′ and 3′ untranslated region (UTR) have been reported in different populations.[@b0015] Some studies have found association of VEGF −460 T/C or +936 C/T polymorphism with ROP risk,[@b0020], [@b0025], [@b0030] but some other studies show no association between VEGF −460 T/C or +936 C/T polymorphism and risk of ROP.[@b0035], [@b0040], [@b0045], [@b0050], [@b0055] These studies revealed a conflicting conclusion, probably due to the relatively small size of subjects, since individual studies are usually underpowered in detecting the effect of low penetrance genes. Therefore, in this study we conducted a meta-analysis to investigate the association between VEGF −460 T/C and +936 C/T polymorphism and the risk for ROP.

Materials and methods {#s0010}
=====================

Identification and eligibility of relevant studies {#s0015}
--------------------------------------------------

To identify all articles that examined the association of VEGF −460 T/C and +936 C/T polymorphism with ROP, we conducted a literature search in the PubMed, EMBASE, Cochrane Library, Google, dogpile and CBM database, up to July 2015 using the following terms and keywords: ''VEGF'', ''vascular endothelial growth factor'', ''−460 T/C" "rs833061" "+936 C/T" "rs3025039" polymorphism'' and ''retinopathy of prematurity''. Additional studies were identified by a manual search from other sources (e.g., Web of Knowledge), references of original studies or review articles on this topic.

Inclusion and exclusion criteria {#s0020}
--------------------------------

The inclusion criteria were as follows: (1) studies are limited to VEGF −460 T/C and +936 C/T polymorphism and ROP; (2) Independent case-control studies using either a hospital-based or a population based design; (3) complete data with genotype and allele frequencies; (4) the literature having a comprehensive statistical index, sufficient data for estimating an odds ratio (OR) with 95% confidence interval (CI); (5) the genotype frequency of cases and controls was within Hardy-Weinberg equilibrium (HWE); (6) papers published in English and (7) all the studies included were according to tenets of the Declaration of Helsinki.

The major reasons for exclusion of studies were (1) studies which were not possible to extract data from the published results; (2) studies that did not report appropriate outcomes; (3) Duplicated studies were also excluded; (4) case-only studies; (5) all three genotype frequency missing and (6) family based studies.

Data extraction {#s0025}
---------------

Authors independently reviewed all the potentially relevant papers through assessing the eligibility of each article and abstracting data with standardized data-abstraction forms. For each study, the following information was extracted: name of the first author; publication year; ethnicity; sample size; types of disease; sources of samples; genotyping methods; and the minor allele frequency in the controls with the Hardy-Weinberg Equilibrium (HWE) *p*-value, respectively. Disagreements were resolved through discussion. The characteristics of these studies included in this meta-analysis on the association of ROP with VEGF −460 T/C and +936 C/T polymorphism are shown in [Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}. The VEGF −460 T/C and +936 C/T polymorphism genotype distributions from each study is presented in [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"} respectively.

Statistical analysis {#s0030}
--------------------

ORs and relevant 95% CIs were computed using review manager (comprehensive meta-analysis version 3).[@b0060] ORs were used to measure association across the studies. The risk of VEGF −460 T/C CC genotype on retinopathy of prematurity was evaluated by comparing with their reference wild type homozygote and then evaluated the risks of TC + CC vs. TT and TT + TC vs. CC on retinopathy of prematurity, assuming dominant and recessive effects of the variant C allele, respectively. And the risk of VEGF + 936 C/T and TT genotype on retinopathy of prematurity was evaluated by comparing with their reference wild type homozygote and then evaluated the risks of CT + TT vs. CC and CC + CT vs. TT on retinopathy of prematurity, assuming dominant and recessive effects of the variant T allele, respectively. If moderate or high level heterogeneity exists, a random-effects meta-analysis was performed, unless using fixed-effects models. Publication bias was assessed by visually inspecting a funnel plot. A *p* value less than 0.05 was considered statistically significant.[@b0065]

Results {#s0035}
=======

Association of the VEGF −460 T/C polymorphism with ROP {#s0040}
------------------------------------------------------

This meta-analysis included four eligible studies of the association of the VEGF −460 T/C polymorphism with ROP. The genetic models all used fixed-effects models. In the overall analysis, no significant associations were found in any of the comparison models including the allele model: T vs. C (OR = 0.931, 95% CI = 0.726--1.195, *P* = 0.576) ([Fig. 1](#f0005){ref-type="fig"}), dominant model: TC + CC vs TT (OR = 0.895, 95% CI = 0.629--1.273, *P* = 0.536) ([Fig. 2](#f0010){ref-type="fig"}), recessive model: TT + TC vs. CC (OR = 1.048, 95% CI = 0.646--1.699, *P* = 0.849) ([Fig. 3](#f0015){ref-type="fig"}) and co-dominant model: TT vs. CC (OR = 0.911, 95% CI = 0.537--1.544, *P* = 0.729) ([Fig. 4](#f0020){ref-type="fig"}).

Association of the VEGF +936 C/T polymorphism with ROP {#s0045}
------------------------------------------------------

A total of four studies were included in this meta-analysis. No significant associations between the VEGF +936 C/T polymorphism with ROP were identified in any comparison models, including the allele model: C vs. T (OR = 0.882, 95% CI = 0.610--1.274, *P* = 0.502) ([Fig. 5](#f0025){ref-type="fig"}), dominant model: CT + TT vs. CC (OR = 0.866, 95% CI = 0.558--1.344, *P* = 0.521) ([Fig. 6](#f0030){ref-type="fig"}), recessive model: CC + CT vs. TT (OR = 1.139, 95% CI = 0.487--2.665, *P* = 0.764) ([Fig. 7](#f0035){ref-type="fig"}) and co-dominant model: CC vs. TT (OR = 0.819, 95% CI = 0.347--1.931, *P* = 0.648) ([Fig. 8](#f0040){ref-type="fig"}).

Sensitivity analysis and publication bias {#s0050}
-----------------------------------------

Individual studies were consecutively excluded in the sensitivity analysis to investigate whether the obtained results were robust. The analysis showed that the results obtained in the meta-analysis were statistically robust, because the corresponding combined ORs in all of the separate subgroup analyses were relatively stable when deleting any individual study. The influence of CC genotype at −460 T/C locus on ROP was taken as the analysis index and inverted funnel plot was drawn ([Fig. 9](#f0045){ref-type="fig"}); TT genotype at +936 C/T locus on ROP was taken as the analysis index and inverted funnel plot was drawn ([Fig. 10](#f0050){ref-type="fig"}). Due to the small amount of the included research and imperceptible distribution trends, the inverted funnel plot showed trend symmetry, indicating that the publication bias was not big.

Discussion {#s0055}
==========

As a major factor in angiogenesis, VEGF has attracted attention because of its involvement in abnormalities of vascular development, retinal detachment, and ROP. In the present study, we systemically reviewed all available published studies and performed a meta-analysis to explore the association between the VEGF −460 T/C and +936 C/T polymorphisms and susceptibility to ROP. Our meta-analysis showed that VEGF −460 T/C and +936 C/T polymorphisms were not associated with ROP risk. The deviation most likely indicates a genotyping assay problem with an erroneous gain/loss of homozygous genotypes. The commonly used polymerase chain reaction-restriction fragment length polymorphism analysis for genotyping is reported to have poor accuracy and reproducibility[@b0070] and may underlie this finding. Conversely, effects of sample selection and differences in biological and environmental complexity between samples could also hinder efforts to replicate association in most of the studies which are statistically underpowered. The meta-analysis helps researchers to deal with the diversity of the published data but in general cannot do justice to complex human diseases, which involve multiple genetic and environmental determinants.[@b0075] However, in the total combined data, no evidence for association between the VEGF −634 G/C polymorphism genotyped and risk of ROP was observed. Therefore, the different results across studies may result from small sample size and/or genotyping technique rather than ethnic differences. Since the studies included were very limited, it is necessary to validate the association between VEGF −634 G/C CC polymorphism and ROP risk in future studies. A well-designed meta-analysis can provide valuable information for researchers, policymakers, and clinicians.

In conclusion, the present meta-analysis suggested that VEGF −460 T/C and +936 C/T polymorphism may not be associated with risk for ROP. More epidemiologic studies are suggested to further ascertain the relationship between VEGF −460 T/C and +936 C/T polymorphism and genetic predisposition to ROP.
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###### 

Characteristics of studies included in the VEGF −460 T/C (rs 833061) meta-analysis.

  Study            Year   Country   Ethnicity   Genotyping method      Sample   Case   Control   *p*-Value   References
  ---------------- ------ --------- ----------- ---------------------- -------- ------ --------- ----------- -----------------------------------------
  Vannay et al.    2005   Hungary   Caucasian   Real-time PCR          Blood    86     115       --          PMID: [15635051](pmid:15635051){#ir005}
  Shastry et al.   2007   USA       Caucasian   PCR-RFLP, Sequencing   Blood    61     61        0.892       PMID: [17119993](pmid:17119993){#ir010}
  Kwinta et al.    2008   America   Caucasian   PCR-RFLP               Blood    60     101       0.024       PMID: [18546007](pmid:18546007){#ir015}
  Kaya et al.      2013   Turkey    Asian       PCR-RFLP               Blood    42     31        0.87        PMID: [23094709](pmid:23094709){#ir020}

###### 

Characteristics of studies included in the VEGF +936 C/T (rs 3025039) meta-analysis.

  Study             Year   Country          Ethnicity   Genotyping method   Sample          Case   Control   *p*-Value   References
  ----------------- ------ ---------------- ----------- ------------------- --------------- ------ --------- ----------- -----------------------------------------
  Cooke et al.      2004   United Kingdom   Caucasian   PCR, SSCP, RFLP     Buccal swab     91     97        0.15        PMID: [15161830](pmid:15161830){#ir025}
  Yagi et al.       2011   Japan            Asian       Taq Man             Buccal mucosa   30     34        0.012       --
  Kalmeh et al.     2013   Iran             Asian       PCR-RFLP            Blood           15     66        0.65        PMID: [23644986](pmid:23644986){#ir030}
  Gismondi et al.   2013   USA              Caucasian   PCR                 Blood           43     53        0.11        PMID: [22227643](pmid:22227643){#ir035}

###### 

VEGF −460 T/C (rs833061) polymorphism genotype distribution of each study included in the meta-analysis.

  Author/Year             Genotype frequency   Allele frequency   Dominant model   Recessive model                                                                       
  ----------------------- -------------------- ------------------ ---------------- ----------------- ---- ---- ----- ---- ----- ----- ---- ---- ---- ---- ---- ---- ---- ----
  Vannay et al. (2005)    27                   47                 12               28                61   26   101   71   117   113   27   59   28   87   12   74   26   89
  Shastry et al. (2007)   27                   27                 7                28                26   7    81    41   82    40    27   34   28   33   7    54   7    54
  Kwinta et al. (2008)    32                   18                 10               55                36   10   82    38   146   56    32   28   55   46   10   50   10   91
  Kaya et al. (2013)      17                   18                 7                11                16   4    52    32   38    24    17   25   11   20   7    35   4    27

###### 

VEGF +936 C/T (rs3025039) polymorphism genotype distribution of each study included in the meta-analysis.

  Author/Year              Genotype frequency   Allele frequency   Dominant model   Recessive model                                                                   
  ------------------------ -------------------- ------------------ ---------------- ----------------- ---- --- ----- ---- ----- ---- ---- ---- ---- ---- --- ---- --- ----
  Cooke et al. (2004)      67                   19                 5                68                21   8   153   29   157   37   67   24   68   29   5   86   8   89
  Yagi et al. (2007)       14                   14                 2                27                7    0   42    18   61    7    14   16   27   7    2   28   0   34
  Kalmeh et al. (2013)     12                   1                  2                43                15   8   25    5    101   31   12   3    43   23   2   13   8   58
  Gismondi et al. (2013)   31                   11                 1                28                23   2   73    13   79    27   31   12   28   25   1   42   2   51
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